Copyright © Inderes 2011 - present. All rights reserved.
Kirjaudu sisään Inderes Free -tilillesi nähdäksesi kaikki sivun maksuton sisältö.
Luo ilmainen tunnus

OrganoClick

1,45 SEK

−0,68 %

Alle 1K seuraajaa

ORGC

First North Stockholm

Chemicals

Basic Materials

−0,68 %
−3,33 %
−17,14 %
−14,20 %
−18,54 %
−34,97 %
−59,37 %
−86,51 %
−79,63 %

OrganoClick operates in environmental technology. The company offers specialized solutions based on fiber-based materials, where the company develops, produces and markets functional fiber chemistry. The products are mainly used in water-repellent fabrics and primarily in wood treatment to protect against fungal decay and fire. The company was founded in 2006 and has its headquarters in Täby.

Lue lisää
Markkina-arvo
159,5 milj. SEK
Vaihto
34,91 t. SEK
Liikevaihto
EBIT %
P/E -luku
Osinkotuotto %
Liikevaihto ja EBIT-%

Liikevaihto milj.

EBIT-% (oik.)

EPS ja Osinko

EPS (oik.)

Osinko %

Pörssikalenteri
6.5.
2026

Osavuosikatsaus Q1'26

20.5.
2026

Yhtiökokous '26

17.7.
2026

Osavuosikatsaus Q2'26

NäytäKaikki sisältötyypit
Kolmannen osapuolen analyysi

OrganoClick: Soft end to 2025, better setup into 2026 - ABG

* Q4 sales -16% vs. ABGSCe, miss in GC&MP and FW * NW&FT showing positive signs; we see a return to growth in '26e * We cut '26e-'27e sales by 7% on weaker-than-expected report Q4 results OrganoClick reported Q4 sales of SEK 18m (-16% vs. ABGSCe) and...

OrganoClick
Kolmannen osapuolen analyysi

OrganoClick: Positive sales in binders, weak elsewhere - ABG

* Q4 sales SEK 18m (-14% y-o-y), -16% vs. ABGSCe * EBIT adj. of SEK -11m (vs. ABGSCe -5.5m) * NW&FT showing signs of improvement, weaker GC&MP and FW Q4 results Sales came in at SEK 18m (-16% vs. ABGSCe 22m), -14% y-o-y (-14% org.). NW&FT increased sales...

OrganoClick

Liity Inderesin yhteisöön

Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.

FREE-tili
Pörssin suosituin aamukatsaus
Analyytikon kommentit ja suositukset
Osakevertailu
PREMIUM-tili
Kaikki yhtiöraportit ja sisällöt
Premium-työkalut (mm. sisäpiirin kaupat ja screeneri)
Mallisalkku
Luo ilmainen tunnus
Kolmannen osapuolen analyysi

OrganoClick: Expecting to see early signs of recovery - ABG

* Q4e sales SEK 22m (21m), EBIT adj. SEK -5.5m (-6.9m) * We expect NW&FT to start showing early signs of recovery * Trading at '26e-'27e EV/Sales 2.2x-2.0x Q4 expectations For Q4, we estimate sales of SEK 22m, +2% y-o-y and -3% q-o-q (NW&FT: +7% y-o-...

OrganoClick
Kolmannen osapuolen analyysi

OrganoClick: Cost savings to cushion volume headwinds - ABG

* Q3 soft, lower volumes from two major customers* We cut '26e-'27e sales and EBIT by 6% and SEK 6m, respectively* Expect volume recovery to take longer than initially projectedQ3 challenging, but cost savings aheadQ3 sales were lower than expected at...

OrganoClick
Kolmannen osapuolen analyysi

OrganoClick: Challenging Q3, but cost-cutting underway - ABG

* Q3 sales SEK 22m (-22% y-o-y), EBIT -6.4m (vs. ABGSCe -4.9m)* Lower volumes from two major customers due to timing effects* Cost savings program of ~SEK 14m announcedQ3 resultsSales came in lower than expected at SEK 22m (-18% vs. ABGSCe 27m), -22%...

OrganoClick
Kolmannen osapuolen analyysi

OrganoClick: Expect gains in GCMP, pressure elsewhere - ABG

* Report out on 5 November* Q3e sales of SEK 27m (29m), EBIT SEK -5m (-3m)* GC&MP the bright spot, other segments under pressureQ3 expectationsQ3 marks the beginning of the second half of the year, which is typically weaker for OrganoClick (particularly...

OrganoClick
Kolmannen osapuolen analyysi

OrganoClick - Near-term weakness in FW & NWFT to linger - ABG

Q2 figures pre-announced OrganoClick reported sales of SEK 30m (-23% y-o-y) and EBIT of -4.7m (-0.1m), in line with the 11 July profit warning. The miss was broad-based compared to estimates from our preview (pre-PW). NW&FT sales were -28% vs. ABGSCe...

OrganoClick
Kolmannen osapuolen analyysi

OrganoClick: Q2 in line with PW, rights issue announced - ABG

Q2 figures in line with pre-announcement The Q2 figures were in line with the profit warning issued on 11 July, i.e. sales of SEK 30m (-23% y-o-y) and an EBIT of SEK -4.7m (-0.1m). FW sales were, as pre-announced in the PW, SEK 10.6m (-34% y-o-y). Sales...

OrganoClick
Inderesin vastuuvapauslauseke löytyy täältä. Kunkin Inderesin aktiivisessa seurannassa olevan osakkeen tarkemmat tiedot löytyvät kunkin osakkeen omilta yhtiösivuilta Inderes-sivustolla. © Inderes Oyj. Kaikki oikeudet pidätetään.